{"id":"https://openalex.org/W2073798285","doi":"https://doi.org/10.1177/0091270008323754","title":"Gender Has a Small but Statistically Significant Effect on Clearance of CYP3A Substrate Drugs","display_name":"Gender Has a Small but Statistically Significant Effect on Clearance of CYP3A Substrate Drugs","alternate_titles":[],"publication_year":2008,"publication_date":"2008-11-01","ids":{"openalex":"https://openalex.org/W2073798285","doi":"https://doi.org/10.1177/0091270008323754","mag":"2073798285","pmid":"https://pubmed.ncbi.nlm.nih.gov/18757784"},"language":"en","primary_location":{"id":"doi:10.1177/0091270008323754","doi":"https://doi.org/10.1177/0091270008323754","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270008323754","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073798285"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087737186","display_name":"David J. Greenblatt","orcid":"https://orcid.org/0000-0003-4719-6226","observed_orcids":["https://orcid.org/0000-0003-4719-6226"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David J. Greenblatt","raw_affiliation_strings":["Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111, USA. dj.greenblatt@tufts.edu","Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111, USA. dj.greenblatt@tufts.edu","institution_ids":["https://openalex.org/I121934306"]},{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111711726","display_name":"Lisa Lvon Moltke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa L. von Moltke","raw_affiliation_strings":["Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087737186"],"corresponding_institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.9414,"has_fulltext":false,"cited_by_count":126,"citation_normalized_percentile":{"value":0.58455882,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"48","issue":"11","first_page":"1350","last_page":"1355"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13252","display_name":"Sex and Gender in Healthcare","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gender-differences","display_name":"gender differences","score":0.796999990940094},{"id":"https://openalex.org/keywords/cyp3a","display_name":"CYP3A","score":0.9459999799728394},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.8920000195503235},{"id":"https://openalex.org/keywords/sex-differences-in-drug-metabolism","display_name":"sex differences in drug metabolism","score":0.8429999947547913},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7739999890327454},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8619999885559082},{"id":"https://openalex.org/keywords/healthy-young-adults","display_name":"healthy young adults","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.6793451309204102},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.471832811832428},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4698922634124756},{"id":"https://openalex.org/C2777289219","wikidata":"https://www.wikidata.org/wiki/Q7632154","display_name":"Substrate (aquarium)","level":2,"score":0.4556293189525604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40594953298568726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26630568504333496},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.08964619040489197},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0091270008323754","doi":"https://doi.org/10.1177/0091270008323754","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270008323754","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:18757784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18757784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4543083441","display_name":"CYP3A Function in Aging AfricanAmericans","funder_award_id":"R01AG017880","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G8706540854","display_name":"MDR1 and Related Proteins during HIV PI Exposure","funder_award_id":"R21AI058784","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W161523339","https://openalex.org/W1734683373","https://openalex.org/W1892429132","https://openalex.org/W1965518725","https://openalex.org/W1967797994","https://openalex.org/W1967884144","https://openalex.org/W1968464659","https://openalex.org/W1968825227","https://openalex.org/W1978599196","https://openalex.org/W1978921548","https://openalex.org/W1981328065","https://openalex.org/W1982281684","https://openalex.org/W1983260781","https://openalex.org/W1984574841","https://openalex.org/W1989740023","https://openalex.org/W1997538585","https://openalex.org/W2015500397","https://openalex.org/W2016643416","https://openalex.org/W2020738884","https://openalex.org/W2036140594","https://openalex.org/W2060317640","https://openalex.org/W2064883756","https://openalex.org/W2068953489","https://openalex.org/W2082979826","https://openalex.org/W2086179586","https://openalex.org/W2087082360","https://openalex.org/W2092435827","https://openalex.org/W2113011757","https://openalex.org/W2115722806","https://openalex.org/W2118836416","https://openalex.org/W2127059331","https://openalex.org/W2127477409","https://openalex.org/W2133866312","https://openalex.org/W2134480524","https://openalex.org/W2145542533","https://openalex.org/W2155268095","https://openalex.org/W2158333644","https://openalex.org/W2165911703","https://openalex.org/W2312400319","https://openalex.org/W2339690013","https://openalex.org/W2402401288","https://openalex.org/W2414435268"],"related_works":["https://openalex.org/W2126906384","https://openalex.org/W2064883756","https://openalex.org/W2158333644","https://openalex.org/W2172119486","https://openalex.org/W2056637444","https://openalex.org/W2113011757","https://openalex.org/W2359517566"],"abstract_inverted_index":{"The":[0,72],"role":[1],"of":[2,7,46,61,80],"gender":[3,122],"on":[4,135],"the":[5,77,109,116],"disposition":[6],"drugs":[8,49,63],"metabolized":[9],"by":[10,69,142],"cytochrome":[11],"P4503A":[12],"(CYP3A)":[13],"remains":[14],"controversial.":[15],"Some":[16],"sources":[17],"suggest":[18],"that":[19,25],"CYP3A":[20,47,136],"activity":[21],"in":[22,26,43,52],"women":[23],"exceeds":[24],"men,":[27],"but":[28],"evidence":[29],"to":[30,115],"support":[31],"this":[32],"position":[33],"is":[34],"inconsistent":[35],"at":[36],"best.":[37],"We":[38],"evaluated":[39],"38":[40],"data":[41],"sets":[42],"which":[44],"clearance":[45,82,111],"substrate":[48,66],"was":[50,64,83,113],"studied":[51],"healthy":[53],"young":[54,57],"male":[55],"and":[56,89,126],"female":[58],"subjects.":[59],"None":[60],"these":[62],"a":[65,124],"for":[67,76,86,92,138],"transport":[68],"P-glycoprotein":[70],"(P-gp).":[71],"overall":[73],"mean":[74],"(+/-SE)":[75],"female/male":[78,110],"ratio":[79,112],"weight-normalized":[81],"1.26":[84],"(+/-0.07)":[85,91],"parenteral":[87],"dosage":[88,107],"1.17":[90],"oral":[93,106,119],"dosage.":[94],"Both":[95],"ratios":[96],"were":[97],"significantly":[98],"different":[99],"(P":[100],"<":[101],".05)":[102],"from":[103],"1.0.":[104],"For":[105],"studies,":[108],"unrelated":[114],"drug's":[117],"absolute":[118],"bioavailability.":[120],"Thus":[121],"has":[123],"small":[125],"statistically":[127],"significant,":[128],"although":[129],"most":[130],"likely":[131],"clinically":[132],"unimportant,":[133],"influence":[134],"phenotype":[137],"substrates":[139],"not":[140],"transported":[141],"P-gp.":[143]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073798285","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
